Valuation: LifeVantage Corporation

Market Cap 74.79M 66.64M 61.7M 55.84M 105M 7.06B 106M 740M 290M 3.71B 281M 275M 11.82B P/E 2027 *
30.5x
P/E 2028 * 18.9x
Enterprise Value 62.11M 55.34M 51.24M 46.37M 87.36M 5.86B 88.39M 614M 241M 3.08B 233M 228M 9.82B EV / Sales 2027 *
0.38x
EV / Sales 2028 * 0.36x
Free-Float
86.31%
Yield 2027 *
-
Yield 2028 * -
1 day-0.34%
1 week+2.59%
Current month-5.56%
1 month-4.34%
3 months-7.03%
6 months+21.18%
Current year-3.41%
1 week 5.93
Extreme 5.9324
6.2
1 month 5.3
Extreme 5.295
6.42
Current year 3.9
Extreme 3.9
11.71
1 year 3.9
Extreme 3.9
11.71
3 years 3.9
Extreme 3.9
27.38
5 years 3.04
Extreme 3.04
27.38
10 years 2.86
Extreme 2.86
27.38
Manager TitleAgeSince
Chief Executive Officer 63 2026-08-04
Director of Finance/CFO 53 2021-10-24
Chief Tech/Sci/R&D Officer - 2026-01-06
Director TitleAgeSince
Director/Board Member 74 2011-12-31
Director/Board Member 67 2017-01-31
Director/Board Member 68 2022-02-16
Date Insider Type Main position Quantity % Market Cap. Importance
10/7/26 Free

Chief Financial Officer

89,372 0.7099%
10/7/26 Free

Responsable ventes & marketing

82,125 0.6523%
10/7/26 Free

Chief Executive Officer

483,092 3.8373%
Change 5-day change 1-year change 3-year change Capi.($)
-0.34%+2.59%-31.05%-16.20% 74.79M
-1.01%+5.13%+58.93%+117.36% 1,144B
-0.61%+1.52%+34.34%+68.48% 625B
-1.48%+0.47%+23.08%+94.76% 511B
+0.54%+5.69%+39.60%+64.02% 377B
+1.07%+1.70%+71.06%+45.98% 366B
+0.30%+3.44%+21.35%+49.62% 291B
-0.03%+6.04%+0.40%+20.94% 262B
-0.14%+2.87%+45.56%+57.22% 237B
-1.88%+0.02%+23.77%+97.39% 194B
Average -0.07%+4.73%+28.70%+59.96% 400.8B
Weighted average by Cap. +0.33%+4.88%+40.76%+79.56%

Financials

2027 *2028 *
Net sales 165M 147M 137M 124M 233M 15.61B 235M 1.64B 642M 8.21B 621M 608M 26.15B 168M 149M 138M 125M 236M 15.82B 239M 1.66B 651M 8.32B 629M 616M 26.5B
Net income 2.49M 2.22M 2.05M 1.86M 3.5M 235M 3.54M 24.62M 9.66M 123M 9.34M 9.14M 393M 4M 3.56M 3.3M 2.98M 5.62M 377M 5.69M 39.53M 15.51M 198M 14.99M 14.68M 632M
Net Debt -12.68M -11.3M -10.46M -9.47M -17.84M -1.2B -18.05M -125M -49.23M -629M -47.58M -46.59M -2B -14.88M -13.26M -12.28M -11.11M -20.93M -1.4B -21.18M -147M -57.75M -738M -55.82M -54.65M -2.35B
Projected Income Statement - Annual - LifeVantage Corporation
Logo LifeVantage Corporation
LifeVantage Corporation is an activation company, which is engage in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, weight management products, pre- and pro-biotics, skin and hair care products, and nootropics. The Company’s line of scientifically validated activators includes the flagship Protandim family of products, TrueScience Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System , as well as AXIO nootropic energy drink mixes, the full TrueScience line of skin and hair care products, and Petandim, a pet supplement formulated to combat oxidative stress in dogs. It sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore.
Employees
216
Date Price Change Volume
26-10-21 US$5.950 -0.34% 30,276
26-10-20 US$5.970 -0.17% 22,805
26-10-19 US$5.980 -0.33% 26,981
26-10-16 US$6.000 0.00% 14,640
26-10-15 US$6.000 +3.45% 41,070
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - LifeVantage Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
5.950USD
Average target price
7.500USD
Spread / Average Target
+26.05%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - LifeVantage Corporation
  1. Stock Market
  2. Stocks
  3. LFVN Stock